- Home
- SABS vs MIRA Comparison
SABS vs MIRA Comparison
Compare SABS & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SABS
- MIRA
- Stock Information
- Founded
- SABS 2014
- MIRA 2020
- Country
- SABS United States
- MIRA United States
- Employees
- SABS N/A
- MIRA N/A
- Industry
- SABS Biotechnology: Pharmaceutical Preparations
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- SABS Health Care
- MIRA Health Care
- Exchange
- SABS Nasdaq
- MIRA Nasdaq
- Market Cap
- SABS 23.9M
- MIRA 21.2M
- IPO Year
- SABS N/A
- MIRA 2023
- Fundamental
- Price
- SABS $3.34
- MIRA $1.09
- Analyst Decision
- SABS Strong Buy
- MIRA Strong Buy
- Analyst Count
- SABS 5
- MIRA 2
- Target Price
- SABS $12.40
- MIRA $14.00
- AVG Volume (30 Days)
- SABS 83.3K
- MIRA 493.9K
- Earning Date
- SABS 11-06-2024
- MIRA 11-12-2024
- Dividend Yield
- SABS N/A
- MIRA N/A
- EPS Growth
- SABS N/A
- MIRA N/A
- EPS
- SABS N/A
- MIRA N/A
- Revenue
- SABS $1,512,723.00
- MIRA N/A
- Revenue This Year
- SABS N/A
- MIRA N/A
- Revenue Next Year
- SABS N/A
- MIRA N/A
- P/E Ratio
- SABS N/A
- MIRA N/A
- Revenue Growth
- SABS N/A
- MIRA N/A
- 52 Week Low
- SABS $2.16
- MIRA $0.51
- 52 Week High
- SABS $7.70
- MIRA $5.01
- Technical
- Relative Strength Index (RSI)
- SABS 48.06
- MIRA 37.31
- Support Level
- SABS $2.75
- MIRA $1.04
- Resistance Level
- SABS $4.30
- MIRA $1.16
- Average True Range (ATR)
- SABS 0.51
- MIRA 0.10
- MACD
- SABS 0.03
- MIRA -0.02
- Stochastic Oscillator
- SABS 26.11
- MIRA 24.29
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.